PANTHERx is proud to join the Centene family of companies. Through this transaction, we are reaffirming our relentless commitment to transforming lives and removing barriers for individuals living with complex and rare diseases. Read the official press release.

Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals, the leading RNAi therapeutics company, as a very limited distribution pharmacy partner for new drug OXLUMO™ (lumasiran). The drug has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of primary hyperoxaluria type […]

PANTHERx is pleased to announce the receipt of another Pittsburgh Business Times Best Places to Work Award, adding to a history of success. PANTHERx is not afraid to break molds, be nimble, and reimagine programs for better outcomes. This flexibility has always served the organization well, but it is particularly crucial during this time, when […]

Smart Business Magazine has announced that Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, was selected as a 2020 Smart 50 Award honoree. Since 2014, the Pittsburgh Smart 50 Awards have recognized the top executives from the 50 smartest companies in the Greater Pittsburgh region. Honorees are selected for their […]

Ernst & Young LLP (EY US) announced today that Dr. Gordon J. Vanscoy, Chairman & CEO of PANTHERx Rare & RareMed Solutions, was named a 2020 Entrepreneur of The Year® East Central Award winner. As a regional award winner, Dr. Vanscoy is eligible for consideration for the Entrepreneur of The Year National Awards, to be […]